Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-γ-stimulated BV-2 microglial cells

Planta Medica

Volumn 72, Issue 7, 2006, Pages 627-633

  Bae, Eun Ah ^a   Kim, Eun Jin ^a   Park, Jin Sun ^b   Kim, Hee Sun ^b   Ryu, Jong Hoon ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

AP 1; Ginsenoside Rg3; Ginsenoside Rh2; iNOS; Microglia; PKA

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; GAMMA INTERFERON; GINSENOSIDE; GINSENOSIDE RG 3; GINSENOSIDE RH 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; PROTEIN AP 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA BINDING; DRUG INHIBITION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; IC 50; MOUSE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GINSENOSIDES; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

MURINAE;

EID: 33745683962     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931563     Document Type: Article

References (31)

1. Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T, Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull 1963; 11: 759-64
2. Tanaka N, Tanaka O, Shibata S. Chemical studies on the oriental plant drugs. XXVIII. Saponins and sapogenins of ginseng. Stereochemistry of sapogenin of ginsenoside Rb1, Rb2 and Rc. Chem Pharm Bull 1972; 20: 1212-6
3. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T. Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra. Yakugaku Zasshi 1983; 103: 612-22
4. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S et al. Degradation of ginseng saponins under mild acidic conditions. Planta Med 1982; 44: 146-9
5. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. 2004; 27: 61-7
6. + channels. J Pharmacol 1999; 367: 41-9
7. Mochizuki M, Yoo CY, Matsuzawa K, Sato K, Saiki I, Tono-oka S et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside Rg3 of red ginseng. Biol Pharm Bull 1995; 18: 1197-202
8. Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. J Cancer Res 1996; 87: 357-62
9. Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett 2005; 374: 92-7
10. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 2002; 25: 58-63
11. Park EK, Choo MK, Oh JK, Ryu JH, Kim DH. Ginsenoside Rh2 reduces ischemic brain injury in rats. Biol Pharm Bull 2004; 27: 433-6
12. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149: 2736-41
13. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995; 35: 655-77
14. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992; 31: 616-21
15. Ishihara T, Kohno K, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Tryptanthrin inhibits nitric oxide and prostaglandin E2 synthesis by murine macrophages. EurJ Pharmacol 2000; 407: 197-204
16. Chi YS, Lim H, Park H, Kim HP. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 2003; 66: 1271-8
17. Ryu SY, Ock MH, Kim KM. Yomogin inhibits the degranulation of mast cells and the production of nitric oxide in activate in activated RAW264.7 cells. Planta Med 2000; 66: 171-3
18. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY et al. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull 2005; 28: 652-6
19. Barber PA, Demchuk AM, Hirt L, Buchan AM. Biochemistry of ischemic stroke. Adv Neurol 2003; 92:151-64
20. Bartosik-Psujek H, Belniak E, Stelmasiak Z. Markers of inflammation in cerebral ischemia. Neurol Sci 2003; 24: 279-80
21. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK et al. Early biomarkers of stroke. Clin Chem 2003; 49: 1733-9
22. Dolan S, Field LC, Nolan AM. The role of nitric oxide and prostaglandin signaling pathways in spinal nociceptive processing in chronic inflammation. Pain 2000; 86: 311-20
23. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-32
24. Leclercq IA, Farrell GC, Sempoux C, Pena AD, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 2004; 41: 926-34
25. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK et al. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 2003; 523-4: 75-85
26. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003; 26: 1581-4
27. Jongeneel CV. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 1995; 193: 210-6
28. Lowenstein CJ, Alley EW, Rava LP, Snowman AM, Snyder SH, Russell SW et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-γ and lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 9730-4
29. Kim WK, Jang PG, Woo MS, Han IO, Pia HZ, Lee K et al. A new anti-inflammatory agent KL-1037 represses pro-inflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia. Neuropharmacology 2004; 47: 243-52
30. Fiorentino DF, Zlontnik A, Mossman TR, Howard M, O'Garra A. Interlukin-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22
31. Aloisi F, De Simone R, Columba-Cabezas S, Levi G. Opposite effects of interferon-γ and prostaglandin E2 on tumor necrosis factor and interlukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J Neurosci Res 1999; 56: 571-80